Precision medicine research at Karmanos comparing biomarker
By A Mystery Man Writer
Description
A Barbara Ann Karmanos Cancer Institute clinical researcher and her team have received $16,000 to further research in precision medicine for breast cancer treatment. Common Citizen leadership delivered the check to Jailan Elayoubi, M.D. , medical oncologist and member of the Breast Cancer and Phase 1 Clinical Trials Multidisciplinary Teams, in November 2023. Dr. Elayoubi and her team have made significant strides in studying biomarkers and tumor molecular characteristics that may predict sensitivity and
Biomarker development in the precision medicine era: lung cancer
Discovery of primary prostate cancer biomarkers using cross cancer
Halabi et al KCJ19n3 2021
Karmanos Cancer Institute
Lasting bond and exceptional care through genetic counseling leads to rekindled friendship decades later
Processes, Free Full-Text
IN THE NEWS: Sk8 to Eliminate Cancer Ice Show Detroit 2022
Cancer Epigenetics For Precision Medicine: Methods and Protocols
FOX 2, The Doctor Is In: Lung Cancer Awareness
The precision medicine forecasting for oncology trials & therapies
A Randomized, Phase II, Biomarker-Selected Study Comparing
IN THE NEWS: Looking Back: The 'Other' Jerome Horwitz
from
per adult (price varies by group size)